According to MarketsandMarkets™, the Predictive Clinical Biomarkers Market is projected to grow from about USD 8.49 billion ...

Point-of-care testing for common sexually transmitted infections may reduce overuse of antibiotics and improve emergency ...

A recent blood-based hepatitis C virus assay on Nuclein's DASH system highlighted its on-device sample prep, among other features that have been driving its adoption.

Point-of-care PCR testing for STIs in the ED reduced length of stay and improved antibiotic stewardship compared with central laboratory testing.

After COVID-19 NPIs lifted, respiratory infections reverted toward pre pandemic seasonality, with winter peaks for RSV and ...

The pharmacogenomics landscape is evolving from a niche scientific pursuit to a cornerstone of value-based healthcare,” said ...

EST Co-Diagnostics (CODX) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

CoDiagnostics secures its first patent for the Co-Dx PCR platform in Australia, strengthening IP protection as the point-of-care system awaits regulatory clearance.

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

The Australian patent represents the first patent granted for the Company's new point-of-care testing platformSALT LAKE CITY, ...